The effect on HbA1c of reduction of carb intake is one of the most clinically relevant questions for people managing type 2 diabetes or non-diabetic hyperglycaemia (prediabetes) in the UK. HbA1c — a blood marker reflecting average glucose levels over two to three months — is directly influenced by how much carbohydrate you consume, since carbohydrates have the most immediate impact on blood glucose of all macronutrients. This article examines the evidence behind low-carbohydrate diets, how much reduction may be needed, current NHS and NICE guidance, practical steps to reduce carbohydrate intake safely, and when to seek medical advice.

How Carbohydrate Intake Affects Blood Glucose and HbA1c

Carbohydrates are the primary macronutrient responsible for raising blood glucose; reducing intake lowers postprandial glucose spikes, which over time decreases HbA1c — a marker reflecting average blood glucose over two to three months.

Have any more questions about this? Message our pharmaceutical team to get more info →

Carbohydrates are the primary dietary macronutrient responsible for raising blood glucose levels after meals. When carbohydrates are digested, they are broken down into glucose, which enters the bloodstream and triggers the release of insulin from the pancreas. In people with type 2 diabetes or insulin resistance, this process is impaired, leading to prolonged elevations in blood glucose — a state known as postprandial hyperglycaemia.

HbA1c (glycated haemoglobin) is a blood marker that reflects average blood glucose levels over the preceding two to three months. It forms when glucose in the bloodstream binds to haemoglobin within red blood cells. The higher and more sustained the blood glucose levels, the higher the HbA1c reading. In the UK, HbA1c is measured in millimoles per mole (mmol/mol). A reading of 42–47 mmol/mol indicates non-diabetic hyperglycaemia (NDH, sometimes referred to as prediabetes), whilst a reading of 48 mmol/mol or above is used in the diagnosis of diabetes mellitus.

It is important to note that HbA1c may be unreliable in certain conditions, including haemoglobinopathies (such as sickle cell trait or thalassaemia), haemolytic anaemia, recent blood transfusion, pregnancy, and chronic kidney disease (CKD). In these situations, alternative measures of glycaemic control — such as capillary blood glucose monitoring or continuous glucose monitoring (CGM) — may be more appropriate. Your healthcare team can advise on the most suitable monitoring method for your circumstances.

Because carbohydrates have the most direct and immediate effect on blood glucose among all macronutrients, reducing carbohydrate intake can reduce the frequency and magnitude of blood glucose rises after meals. Over time, this may translate into a meaningful reduction in HbA1c. This relationship forms the scientific basis for exploring low-carbohydrate dietary approaches as a management strategy for people living with type 2 diabetes or NDH.

Not all carbohydrates behave identically. Refined carbohydrates (such as white bread, sugary drinks, and processed snacks) cause rapid glucose rises, whilst complex carbohydrates (such as wholegrains, legumes, and non-starchy vegetables) are digested more slowly and have a more modest effect on blood glucose. Portion size, fibre content, and the overall glycaemic load of a meal also influence the blood glucose response.

What the Evidence Says About Low-Carb Diets and HbA1c Reduction

Clinical trials and meta-analyses show low-carbohydrate diets reduce HbA1c by approximately 3–11 mmol/mol at six months, with benefits most evident short-term and tending to attenuate by 12 months due to adherence challenges.

A growing body of clinical evidence supports the role of carbohydrate reduction in lowering HbA1c in people with type 2 diabetes. A systematic review and meta-analysis published in the BMJ (Goldenberg et al., 2021), which pooled data from multiple randomised controlled trials, found that low-carbohydrate and very low-carbohydrate diets produced greater reductions in HbA1c at six months compared with higher-carbohydrate control diets. An earlier systematic review (Snorgaard et al., BMJ Open Diabetes Research & Care, 2017) similarly found short-term glycaemic benefits, whilst noting that differences between dietary approaches tended to attenuate by 12 months. Long-term adherence and the degree of weight loss appear to be important factors in determining sustained benefit.

The Diabetes Remission Clinical Trial (DiRECT), conducted in the UK and published in The Lancet (2018), demonstrated that a structured low-energy total diet replacement (TDR) programme led to remission of type 2 diabetes — defined as HbA1c below 48 mmol/mol without glucose-lowering medication — in nearly half of participants at one year. It is important to clarify that DiRECT was primarily a low-energy intervention targeting substantial weight loss; whilst carbohydrate intake was reduced as part of the overall energy restriction, the programme was not specifically designed as a low-carbohydrate diet. The remission observed is largely attributed to significant weight loss and its effects on insulin resistance.

Key findings from the evidence base include:

• Very low-carbohydrate diets (under 50 g per day) tend to produce the largest short-term reductions in HbA1c, particularly in individuals with higher baseline levels.

• Moderate low-carbohydrate diets (50–130 g per day) also show clinically meaningful improvements in glycaemic control.

• HbA1c reductions observed in trials at approximately six months typically range from around 3 to 11 mmol/mol, depending on baseline HbA1c, adherence, and the degree of weight loss achieved.

• Benefits are most evident at six months and tend to attenuate by 12 months, partly due to challenges with long-term dietary adherence.

• Improvements in HbA1c are mediated not only by reduced carbohydrate intake itself, but also by associated reductions in total energy intake, weight loss, and, in some cases, medication de-escalation.

The evidence does not suggest that carbohydrate reduction is the only effective dietary strategy, but it is among the most well-supported approaches for improving glycaemic control in the short to medium term. Diabetes UK's evidence-based nutrition guidelines (2018, with subsequent updates) explicitly support low-carbohydrate eating as a valid dietary option for people with type 2 diabetes.

How Much Carbohydrate Reduction Is Needed to Lower HbA1c

Very low-carbohydrate diets (under 50 g/day) produce the greatest HbA1c reductions, whilst moderate low-carbohydrate diets (50–130 g/day) also deliver clinically meaningful improvements; individual responses vary considerably.

There is no single universally agreed threshold of carbohydrate reduction required to lower HbA1c, as individual responses vary depending on factors such as baseline HbA1c, body weight, physical activity levels, medication use, and overall metabolic health. However, research provides useful guidance on the relationship between the degree of carbohydrate restriction and glycaemic outcomes.

According to UK National Diet and Nutrition Survey (NDNS) data, average carbohydrate intake in UK adults is approximately 45–50% of total energy intake, equating to roughly 200–250 g per day for many adults, though this varies considerably by age, sex, and dietary pattern.

Dietary approaches are broadly categorised as follows:

• Very low-carbohydrate (ketogenic) diets: Typically fewer than 50 g of total carbohydrates per day. These tend to produce the most rapid reductions in blood glucose and HbA1c, particularly in the short term, but can be difficult to sustain and carry specific safety considerations (see below).

• Low-carbohydrate diets: Generally defined as 50–130 g of carbohydrates per day. These are more sustainable for many people and still demonstrate clinically significant HbA1c reductions in trials.

• Moderate carbohydrate reduction: Reducing intake to around 130–150 g per day — particularly by replacing refined carbohydrates with fibre-rich alternatives — can produce measurable improvements in glycaemic control.

Even modest, targeted reductions — such as eliminating sugary beverages, confectionery, and ultra-processed foods — may contribute to improved HbA1c over time. However, it is important to note that individual responses vary considerably, and the degree of benefit depends on multiple factors including energy balance and weight change. Blanket statements that any carbohydrate reduction will proportionally lower HbA1c are an oversimplification; clinical guidance and monitoring are essential to assess individual response.

Important safety note for people taking SGLT2 inhibitors: Medicines in this class — including empagliflozin (Jardiance), dapagliflozin (Forxiga), canagliflozin (Invokana), and ertugliflozin (Steglatro) — carry a risk of diabetic ketoacidosis (DKA), including euglycaemic DKA (where blood glucose may not be markedly elevated), particularly when carbohydrate intake is very low, during fasting, or during illness. If you are taking an SGLT2 inhibitor, you should seek advice from your GP or diabetes care team before making significant reductions to your carbohydrate intake. The MHRA has issued specific safety guidance on this risk.

Individuals taking sulphonylureas (such as gliclazide) or insulin should also be aware that significant carbohydrate reduction can increase the risk of hypoglycaemia, and medication adjustments may be required under medical supervision.

NHS and NICE Guidance on Low-Carbohydrate Diets for Diabetes

NICE NG28 (updated 2022) and Diabetes UK guidelines support low-carbohydrate diets as a valid individualised option for type 2 diabetes, with emphasis on medication review, nutritional adequacy, and appropriate clinical supervision.

In recent years, both NHS England and the National Institute for Health and Care Excellence (NICE) have updated their positions to reflect the evidence on dietary approaches for people with type 2 diabetes. This represents a shift from earlier guidance, which emphasised a balanced diet with carbohydrates as the primary energy source.

NICE's guideline on type 2 diabetes in adults (NG28, updated 2022) recommends that healthcare professionals offer individualised, evidence-based dietary advice that takes into account the amount and quality of carbohydrate consumed, alongside the person's preferences, goals, and clinical circumstances. NICE supports low-carbohydrate diets as one valid option within this individualised framework, whilst emphasising nutritional adequacy and the need for appropriate medical supervision — particularly regarding medication review.

NHS England has supported the rollout of the NHS Low Calorie Diet Programme, which uses a structured low-energy total diet replacement (TDR) approach to achieve significant weight loss as a pathway to type 2 diabetes remission. This programme is based largely on the DiRECT trial evidence and targets remission primarily through substantial caloric restriction and weight loss; it is not specifically a low-carbohydrate programme, though carbohydrate intake is reduced as part of overall energy restriction.

Diabetes UK's evidence-based nutrition guidelines (2018, with subsequent updates) explicitly support low-carbohydrate eating as a valid dietary strategy for people with type 2 diabetes, alongside other evidence-based approaches such as the Mediterranean diet.

Key points from current UK guidance include:

• Low-carbohydrate diets should be individualised and considered alongside the person's preferences, clinical needs, and any relevant contraindications.

• People taking insulin or sulphonylureas require close monitoring and a prompt medication review when reducing carbohydrate intake, to minimise the risk of hypoglycaemia.

• People taking SGLT2 inhibitors should seek clinical advice before adopting a very low-carbohydrate or ketogenic diet, given the risk of euglycaemic DKA.

• Dietary changes should ideally be supported by a registered dietitian or a structured diabetes education programme such as DESMOND or X-PERT.

• Long-term nutritional balance — including adequate fibre, vitamins, and minerals — must be maintained.

Practical Steps to Reduce Carbohydrate Intake Safely

Effective carbohydrate reduction starts with eliminating sugary drinks and refined carbohydrates, replacing them with non-starchy vegetables, protein, and healthy fats, whilst making changes gradually under medical supervision if on diabetes medication.

Reducing carbohydrate intake does not require an extreme or highly restrictive approach to be effective. For many people, making targeted, sustainable changes to their existing diet can produce meaningful improvements in blood glucose and HbA1c over time. The following practical steps can help guide a safe and gradual reduction in carbohydrate consumption.

Start by identifying high-carbohydrate foods in your current diet:

• Sugary drinks, fruit juices, and energy drinks

• White bread, white rice, and regular pasta

• Breakfast cereals, particularly those high in sugar

• Biscuits, cakes, sweets, and confectionery

• Potatoes (especially chips and crisps)

Replace refined carbohydrates with lower-carbohydrate alternatives:

• Swap white bread for seeded or wholegrain varieties, or reduce portion sizes

• Replace sugary drinks with water, sparkling water, or unsweetened herbal teas

• Choose non-starchy vegetables (such as broccoli, courgette, spinach, and cauliflower) as the base of meals

• Include protein-rich foods (eggs, fish, poultry) and healthy fats (avocado, olive oil, nuts) to improve satiety

• Legumes (such as lentils, chickpeas, and kidney beans) provide fibre and protein but also contain moderate amounts of carbohydrate; be mindful of portion sizes

Read food labels: Check the 'of which carbohydrates' and 'of which sugars' figures per 100 g and per portion. This can help you identify hidden sources of carbohydrate in processed foods and make more informed choices. Many structured diabetes education programmes, such as DESMOND and X-PERT, include carbohydrate awareness and counting skills.

It is advisable to make changes gradually rather than all at once, particularly for those on diabetes medications, to allow for safe monitoring of blood glucose responses. Keeping a food diary or using a blood glucose monitor (if prescribed or recommended by your care team) can help identify which foods have the greatest impact on your individual glucose levels.

If you are taking insulin or a sulphonylurea, always carry fast-acting carbohydrate (such as glucose tablets or a sugary drink) in case of hypoglycaemia, and discuss sick-day rules with your diabetes care team. Hydration is also important, as reducing carbohydrate intake — particularly on a very low-carbohydrate diet — can increase fluid and electrolyte losses in the early stages. Seeking support from a registered dietitian ensures that nutritional needs are met whilst achieving glycaemic goals. NHS patient-facing resources, including the NHS 'Type 2 diabetes – Food and keeping active' pages and Diabetes UK's carbohydrate guidance, provide further practical advice.

When to Seek Medical Advice About Diet and HbA1c Management

Seek medical advice before significantly reducing carbohydrate intake if you take an SGLT2 inhibitor, insulin, or sulphonylurea, or if you have type 1 diabetes, CKD, or are pregnant, as these situations carry specific safety risks requiring clinical oversight.

Whilst dietary changes are generally safe and encouraged for people with type 2 diabetes or non-diabetic hyperglycaemia, there are specific circumstances in which medical advice should be sought before or during any significant reduction in carbohydrate intake. Patient safety is paramount, and certain individuals face particular risks that require professional oversight.

Seek urgent (same-day) medical attention if you experience symptoms that may indicate diabetic ketoacidosis (DKA): These include nausea, vomiting, abdominal pain, rapid or laboured breathing, confusion, or drowsiness — even if your blood glucose reading is not markedly elevated (euglycaemic DKA can occur, particularly in people taking SGLT2 inhibitors). Do not wait for a routine appointment.

Contact your GP or diabetes care team before making significant dietary changes if:

• You are taking an SGLT2 inhibitor (empagliflozin, dapagliflozin, canagliflozin, or ertugliflozin), as very low-carbohydrate or ketogenic diets substantially increase the risk of DKA. The MHRA has issued specific safety guidance on this risk.

• You are taking insulin or sulphonylureas (such as gliclazide), as carbohydrate reduction significantly increases the risk of hypoglycaemia and medication doses may need to be adjusted promptly.

• You experience symptoms of hypoglycaemia (shakiness, sweating, confusion, or palpitations), particularly if these are new or more frequent.

• Your HbA1c or home blood glucose readings change significantly — either improving markedly (which may require medication review) or worsening unexpectedly.

• You have type 1 diabetes, as carbohydrate management in this context requires specialist input and careful insulin adjustment; structured education programmes such as DAFNE are recommended (see NICE NG17).

• You have chronic kidney disease (CKD), as high-protein dietary patterns sometimes associated with low-carbohydrate eating may not be appropriate.

• You are pregnant or planning pregnancy, as dietary requirements differ and specialist dietetic advice is essential.

• You have a history of an eating disorder, are underweight (BMI below 18.5), are frail, or have had bariatric surgery, as these circumstances require tailored dietary guidance.

Regular HbA1c monitoring — typically every three to six months for people with diabetes, in line with NICE NG28 — allows healthcare professionals to assess the effectiveness of dietary changes and adjust treatment plans accordingly. If you are unsure whether a low-carbohydrate diet is appropriate for your individual circumstances, ask for a referral to a registered dietitian with experience in diabetes management.

If you experience a suspected side effect from any medicine, you can report it via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

Reducing carbohydrate intake can be a highly effective and evidence-based strategy for improving HbA1c, but it works best as part of a holistic, medically supported approach to diabetes management.

Frequently Asked Questions